THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 114 filers reported holding THERAVANCE BIOPHARMA INC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,242 | -16.6% | 144 | 0.0% | 0.00% | – |
| Q2 2023 | $1,490 | -4.6% | 144 | 0.0% | 0.00% | – |
| Q1 2023 | $1,562 | -3.3% | 144 | 0.0% | 0.00% | – |
| Q4 2022 | $1,616 | -19.2% | 144 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 144 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | 0.0% | 144 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | – | 144 | +63.6% | 0.00% | – |
| Q4 2021 | $0 | – | 88 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 88 | 0.0% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 88 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | – | 88 | +57.1% | 0.00% | – |
| Q4 2020 | $0 | – | 56 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 56 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | 0.0% | 56 | 0.0% | 0.00% | – |
| Q1 2020 | $2,000 | 0.0% | 56 | 0.0% | 0.00% | – |
| Q4 2019 | $2,000 | 0.0% | 56 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | – | 56 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 56 | 0.0% | 0.00% | – |
| Q1 2019 | $2,000 | 0.0% | 56 | 0.0% | 0.00% | – |
| Q4 2018 | $2,000 | 0.0% | 56 | 0.0% | 0.00% | – |
| Q3 2018 | $2,000 | -50.0% | 56 | -64.1% | 0.00% | – |
| Q2 2018 | $4,000 | +100.0% | 156 | +178.6% | 0.00% | – |
| Q1 2018 | $2,000 | 0.0% | 56 | +55.6% | 0.00% | – |
| Q4 2017 | $2,000 | -99.0% | 36 | -99.4% | 0.00% | – |
| Q3 2016 | $210,000 | +54.4% | 5,800 | -3.2% | 0.00% | – |
| Q2 2016 | $136,000 | +23.6% | 5,992 | +3.3% | 0.00% | – |
| Q1 2016 | $110,000 | +14.6% | 5,800 | 0.0% | 0.00% | – |
| Q4 2015 | $96,000 | +50.0% | 5,800 | 0.0% | 0.00% | – |
| Q3 2015 | $64,000 | -15.8% | 5,800 | 0.0% | 0.00% | – |
| Q2 2015 | $76,000 | -24.0% | 5,800 | -0.3% | 0.00% | – |
| Q1 2015 | $100,000 | +16.3% | 5,815 | +0.3% | 0.00% | – |
| Q4 2014 | $86,000 | -68.1% | 5,800 | -50.4% | 0.00% | – |
| Q3 2014 | $270,000 | +2600.0% | 11,684 | +4014.1% | 0.00% | – |
| Q2 2014 | $10,000 | – | 284 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 7,012,226 | $60,515,510 | 8.59% |
| Irenic Capital Management LP | 2,760,948 | $23,826,981 | 6.76% |
| Newtyn Management, LLC | 1,841,560 | $15,892,663 | 3.92% |
| Weiss Asset Management LP | 7,457,060 | $64,354,428 | 3.81% |
| Park West Asset Management LLC | 1,983,251 | $17,115,456 | 1.57% |
| Baupost Group | 7,419,226 | $64,028 | 1.23% |
| Oasis Management Co Ltd. | 953,254 | $8,226,582 | 0.36% |
| Chescapmanager LLC | 287,333 | $2,479,684 | 0.32% |
| GSA CAPITAL PARTNERS LLP | 325,985 | $2,813 | 0.24% |
| Virtus ETF Advisers LLC | 29,232 | $252,272 | 0.15% |